Status:
COMPLETED
Intracorporeal Nanocomposites and Neurological Disorders in Fulgurates (FulgurnanoF)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
PROMES UPR 8521 DR2-CNRS
LPC UMR 6533, Campus Universitaire des Cézeaux
Conditions:
Neurologic Disorder
Eligibility:
All Genders
7-80 years
Brief Summary
Objective: To demonstrate the presence of bioresistant intracorporeal carbon-based nanocomposites in subjects exposed to a fulguration, in the immediate aftermath of this fulguration and 24 months (+/...
Detailed Description
In order to detect nanocomposites in patients who have been impacted by lightning, an analysis protocol will be performed on the remains of blood and urine samples from their initial medical admission...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Patients exposed: all subjects who were victims of the fulguration accident.
- Non-exposed patients:
- 14 subjects,
- of all ages,
- free of major pathology and having never been the victim of a fulguration accident, nor having witnessed a fulguration at less than 20 meters,
- having never worked in a high-energy environment (CEA, EDF, particle accelerator, AREVA-type laboratory, radiology manipulator, radiation protection profession).
- Exclusion criteria :
- Pregnant or breastfeeding woman.
- Subject under guardianship, curatorship or safeguard of justice, or deprived of liberties.
- Any condition judged by the investigator to be incompatible with the research.
- Refusal to participate. Exposed patients: if the above-mentioned accident induced more than a simple lightning strike (lightning: died by lightning, electrocution: touched by an electric current, electrocution: died by contact with an electric current).
Exclusion
Key Trial Info
Start Date :
May 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04380194
Start Date
May 20 2019
End Date
September 10 2020
Last Update
September 11 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Henri Mondor
Aurillac, France
2
CH de Luneville
Lunéville, France
3
CHRU Bradois
Nancy, France
4
CHRU de Nancy
Nancy, France